65% of vaccines manufactured in Hyderabad, says Krishna Ella
By IANS |
Published on
Mon, Feb 22 2021 18:03 IST |
1 Views
65 percent of vaccines are manufactured in Hyderabad, says Krishna Ella. Image Source: IANS News
Hyderabad, Feb 22 : Almost 65 per cent of all vaccines manufactured in India and exported around the world come from Hyderabad, Bharat Biotech Chairman and Managing Director Dr Kishna Ella said on Monday.
He said that there is no cluster like Hyderabad s Genome Valley anywhere in the world which contributes such huge volumes.
He was speaking after receiving Genome Valley Excellence Award at the inaugural session of Bio Asia 2021, the 18th edition of Asia s biggest life science and healthcare industry conference.
65% of vaccines manufactured in Hyderabad, says Bharat Biotech s Krishna Ella
SECTIONS
Last Updated: Feb 22, 2021, 06:20 PM IST
Share
Synopsis
Krishna Ella, whose firm developed India s first indigenous vaccine for Covid-19, said pandemic vaccines and everything in future will come from Hyderabad .
Bharat Biotech received the award for breakthrough, pioneering research, development and commercialization of vaccines.
2,944,771.0
Almost 65 per cent of all vaccines manufactured in India and exported around the world come from Hyderabad, Bharat Biotech Chairman and Managing Director Dr Kishna Ella said on Monday.
He said that there is no cluster like Hyderabad s Genome Valley anywhere in the world which contributes such huge volumes.
Bharat Biotech hails Rs 35,000 crore budget allocation for COVID-19 vaccination
SECTIONS
Last Updated: Feb 01, 2021, 05:29 PM IST
Share
Synopsis
Welcoming the proposal for Rs 35,000 crore outlay for COVID-19 vaccines, city-based Bharat Biotech Chairman and Managing Director Krishna Ella said Its a great step ahead, and far-reaching budget announcement., providing Rs 35,000 crore for COVID-19 vaccination in 2021-22.
Getty Images
Hyderabad: Covaxin maker Bharat Biotech on Monday described as far reaching initiative the allocation of Rs 35,000 crore for COVID-19 vaccination in the Union Budget and said it would help the country become free of the viral disease. Dr. Reddys Laboratories Ltd said the budget was growth- oriented with a lot of positive interventions and with something in it for everyone .
SII, Bharat Biotech Welcome Enhanced Focus on Health, Immunisation in Budget
FOLLOW US ON:
Leading vaccine manufacturers Serum Institute of India and Bharat Biotech on Monday applauded the government s increased allocation for the healthcare sector and on providing Rs 35,000 crore towards COVID-19 vaccination in 2021-22 fiscal. I have provided Rs 35,000 crore for COVID-19 vaccine in this year 2021-22. I m committed to provide further funds if required. The Budget outlay for health and well being is Rs 2.23 lakh crore in 2021-22 as against BE of Rs 94,452 crore and marks an increase of 137 per cent, she said while presenting 2021-22 Budget in the Lok Sabha.
Monday described as far reaching initiative the allocation of Rs 35,000 crore for COVID-19 vaccination in the Union Budget and said it would help the country become free of the viral disease. Dr. Reddys Laboratories Ltd said the budget was growth- oriented with a lot of positive interventions and with something in it for everyone . Welcoming the proposal for Rs 35,000 crore outlay for COVID-19 vaccines, city-based Bharat Biotech Chairman and Managing Director Krishna Ella said Its a great step ahead, and far-reaching budget announcement., providing Rs 35,000 crore for COVID-19 vaccination in 2021-22. The Finance Minister s commitment providing more funds in order to contain the coronavirus pandemic and provide an effective, smooth path for the vaccination scheme will help contain, and lead our nation towards accomplishing a COVID-19 disease free Bharat, he said in statement here.